Children’s Hospitals and Clinics of Minnesota has tapped San Francisco-based Welkin Health for a multi-year study looking to improve care for children with type 1 diabetes.

Said study aims to identify patterns and predictors that lead to serious events related to type 1 diabetes, prevent long term complications of the disease, and provide real-time intervention for children managing their health. The first phase is currently underway and is expected to be completed in the summer of 2016.

Under the deal, Welkin’s software will provide a workflow tool configured to the study’s protocol to ensure no patient falls through the cracks. Using it, any team member can communicate with any patient or family member through built-in text or email regardless of where the team or family member may be.

“Our software provides a daily workflow uniquely tailored to each team member based on the program protocol the team is following,” Chase Hensel, Welkin co-founder and CEO, said in a statement. “Care teams that need to engage patients, deliver care, or support self-management remotely will find it valuable. We’re proud to be a part of Children’s’ study and think we will help the organization make a significant impact.”

Children’s Hospitals and Clinics of Minnesota has the largest treatment program for kids with type 1 diabetes in the state. Its 36-member diabetes and endocrine team treats patients from birth to age 22.

In July 2015, Welkin Health raised $2 million for its disease management coaching service.

[Via: HITconsultant]